A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects

NCT02096666 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen